US 8217038
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
granted A61PA61P1/16A61P29/00
Quick answer
US patent 8217038 (Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes) held by Jenrin Discovery, LLC expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Jenrin Discovery, LLC
- Grant date
- Tue Jul 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P1/16, A61P29/00, A61P3/04, A61P3/06